Trigeminal nerve transposition by sling-pulling technique in combination with macrovascular transposition for giant basilar artery–induced trigeminal neuralgia via a combined transpetrosal approach - Scorecard - MDSpire
Advertisement
Trigeminal nerve transposition by sling-pulling technique in combination with macrovascular transposition for giant basilar artery–induced trigeminal neuralgia via a combined transpetrosal approach
Clinical Scorecard: Sling-Pulling Technique for Trigeminal Nerve Transposition Combined with Macrovascular Transposition in Treating Giant Basilar Artery-Induced Trigeminal Neuralgia via a Transpetrosal Approach
At a Glance
Category
Detail
Condition
Trigeminal neuralgia caused by giant dolichoectatic basilar artery (DBA) compression
Key Mechanisms
Mechanical compression of trigeminal nerve root exit zone (TGN-REZ) by a gigantic DBA
Target Population
Patients with refractory trigeminal neuralgia due to giant DBA, especially those intolerant or allergic to carbamazepine
Giant DBA-induced trigeminal neuralgia is rare and challenging with high failure and recurrence rates after conventional microvascular decompression (MVD).
The sling-pulling technique for trigeminal nerve transposition combined with macrovascular transposition (MaVT) via CTPA provides durable decompression and favorable outcomes.
CTPA allows optimal exposure, enlargement of posterior fossa space, and safe manipulation of the giant DBA and trigeminal nerve.
Guideline-Based Recommendations
Diagnosis
Use brain imaging to identify giant DBA compressing the trigeminal nerve root exit zone.
Assess clinical presentation of typical trigeminal neuralgia symptoms refractory to medication.
Management
First-line treatment is carbamazepine; consider surgery if refractory or allergic.
Surgical options include microvascular decompression (MVD), microvascular transposition (MVT), and macrovascular transposition (MaVT).
For giant DBA-induced TGN, perform combined trigeminal nerve transposition using sling-pulling technique and MaVT via combined transpetrosal approach (CTPA).
Monitoring & Follow-up
Postoperative monitoring for facial hypoesthesia and facial palsy; expect possible transient facial palsy resolving within months.
Long-term follow-up to assess pain relief and recurrence.
Risks
Potential facial palsy (House-Brackmann grade 3) and hypoesthesia postoperatively.
Technical challenges and higher complication rates with MVT compared to conventional MVD.
Risk of vascular kinking and perforator injury mitigated by thorough arachnoid dissection and careful transposition.
Patient & Prescribing Data
Patients with typical trigeminal neuralgia refractory to carbamazepine or with carbamazepine allergy, caused by giant DBA compression
Carbamazepine is first-line but may be ineffective or intolerable; surgical intervention with sling-pulling trigeminal nerve transposition and MaVT offers durable pain relief and symptom resolution.
Clinical Best Practices
Perform thorough arachnoid dissection to free neurovascular structures and preserve function during surgery.
Open Meckel’s cave to mobilize the trigeminal nerve for effective transposition.
Anchor the trigeminal nerve permanently using a non-absorbable biological patch fixed to temporal dura via sling-pulling technique.
Use Teflon felt soaked in fibrin glue to support and reposition the giant DBA safely.
Employ combined transpetrosal approach (CTPA) for optimal surgical exposure and enlargement of posterior fossa space.
Monitor and manage postoperative facial nerve function; expect possible transient palsy with potential full recovery.